Effect of obesity and weight loss on arginine vasopressin response to metoclopramide and nicotine from cigarette smoking.
We have previously reported an impaired arginine vasopressin (AVP) response to insulin-induced hypoglycemia in obese men, suggesting a hypothalamic-posterior pituitary disorder in obesity. In the present study, we examined the AVP response to other releasing stimuli with a central site of action. The AVP response of 10 obese men to metoclopramide (MCP) or nicotine inhaled with cigarette smoking was compared with that obtained in eight sex- and age-matched controls. The AVP increase during nicotine and MCP tests were significantly lower in the obese patients than in the normal controls. Obese men were restudied after substantial weight loss. The AVP response to nicotine and MCP administration was significantly higher than before slimming and did not differ from that observed in the normal weight subjects. These results demonstrate obesity-related alterations in the AVP responsiveness to nicotine inhaled with cigarette smoking and MCP, supporting the hypothesis for a hypothalamic-posterior pituitary disorder in obesity.
Chiodera
P
P
Cattedra di Endocrinologia e Patologia Costituzionale, Università di Parma, Italy.
Capretti
L
L
Davoli
C
C
Caiazza
A
A
Bianconi
L
L
Coiro
V
V
D000328:Adult; D001127:Arginine Vasopressin / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D008297:Male; D008787:Metoclopramide; D009538:Nicotine / Q000494:pharmacology*; D009765:Obesity / Q000097:blood / Q000503:physiopathology*; D012016:Reference Values; D012907:Smoking / Q000097:blood / Q000503:physiopathology*; D013997:Time Factors; D015431:Weight Loss
D001127:Arginine Vasopressin; D009538:Nicotine; D008787:Metoclopramide